Synaptodendritic injury with HIV-Tat protein: What is the therapeutic target?
Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA; Translational Neuroscience Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. Electronic address: natha@ninds.nih.gov.
Avindra
A
Nath
Translational Neuroscience Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Joseph
J
Steiner
D000818:Animals; D016923:Cell Death / Q000187:drug effects*; D006624:Hippocampus / Q000187:drug effects*; D009154:Mutation; D009474:Neurons / Q000187:drug effects*; D054322:tat Gene Products, Human Immunodeficiency Virus / Q000494:pharmacology*
D054322:tat Gene Products, Human Immunodeficiency Virus